NIROLIN is involved in the development and introduction of professional anti-aging cosmetics as well as other products that address various skin problems such as acne, pigmentation, eczema, and more.
NIROLIN has developed a unique commercial model that operates successfully in the domestic market and is in the process of penetrating international markets. The model refers to the product distribution chain and combines capital, marketing, and science; Entrepreneurs with knowledgeable in marketing experienced chemists, financial companies, leading skincare specialists, and dermatologies.
The marketing model has brought a unique benefit to the end customer by being able to enjoy a high-quality professional product, which includes research-proven active ingredients, at required high concentrations, and competitive price tailored to the target market.
As a company that sets our goal of improving the quality of life to our customers, We've made a breakthrough in the distribution of our products
Nirolin delivers professional products in direct marketing, quality products that, in the past, could only be obtained in the professional market reach directly to the customer's home. NIROLIN specializes in market research intending to characterize the end-users habits in the target market and offer it an exact product that meets its needs.
In 2012, we founded three young academic entrepreneurs, Nir Ronen and Lior Nirolin, when we set ourselves the goal of researching the truth in aesthetics and skin health and distributing it to the mass market.
From its inception, the company is full of energy, with a fruitful collaboration with the most professional chemists, dermatologists, and akin care specialists in the global market. Together, hand in hand, we discover innovative technologies and unique raw materials, unveiling and developing aesthetic and paramedical cosmetics, with the highest quality mark with tangible, visible results.
After rigorous testing of the products and satisfaction with the results, we distribute our disclosures among our many satisfied customers.
In 2013, the company made a significant leap thanks to an investment agreement with an international biopharmaceutical company, Gillbood Trading S.A., led by Mr. Avi Meizler, founder of "Meizler Biopharma.", The company Founded in 1990 to promote the development of health in Brazil, specializes in-licensing and acquisition of new drugs and existing partnerships with the world's leading pharmaceutical/biotech and device doctors.
Nirolin's vision is to lead the aesthetic and dermo-cosmetics market by identifying and developing the highest quality products based on innovative medical technologies and distributing them through unique distribution mechanisms.
Including no compromises regarding the quality of the products, at Nirolin, we maintain a high level of service, provide various solutions to our customers and provide a professional response in the area of skin health and care.
Today Nirolin is in line with the world's leading aesthetic and cosmetic dermo-cosmetics companies